Google Alert - pharmaceutical news

News8 new results for pharmaceutical news Spectrum Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare ...MarketWatch (press release)HENDERSON, Nev., May 31, 2012 (BUSINESS WIRE) -- Spectrum Pharmaceuticals (nasdaqgs:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an ...See all stories on this topic »Catabasis Pharmaceuticals Appoints Henry Rath to Vice President, Business ...MarketWatch (press release)CAMBRIDGE, Mass., May 31, 2012 (BUSINESS WIRE) -- Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and ...See all...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE FinancingSacramento BeeBy AcelRx Pharmaceuticals, Inc. REDWOOD CITY, Calif., May 30, 2012 -- /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the ...See all stories on this topic »Sun's key appointments lay the foundation for global growthHindu Business LineMr Israel Makov, former Chief Executive of Teva Pharmaceutical Industries, had just recently taken over as Chairman Bio-Light, they add. Whether Mr Shanghvi and Mr Makov knew each other earlier, or last year's deal brought them together – the alliance ...See all stories on this topic »Auxilium Pharmaceuticals,...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news US business, branded generics boost Sun Pharma Q4 numbersHindu Business LineSun Pharmaceutical Industries posted net sales of Rs 2330 crore for the three months ended March 31, a growth of 59 per cent over same quarter last year. The company registered a net profit of Rs 820 crore, equivalent to 35 per cent net margin, ...See all stories on this topic »Hindu Business LineThe Pharmaceutical Market: USAMarketWatch (press release)Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.See all stories on this topic »Ranbaxy gets...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news /REPEAT -- Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOIN/MarketWatch (press release)Cipher Pharmaceuticals Inc. (TOR:CA:DND) announced today that the US Food and Drug Administration (FDA) has approved Absorica™, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant ...See all stories on this topic »Ranbaxy gets US OK for acne treatmentReuters IndiaThe product was jointly developed by Canadian group Cipher Pharmaceuticals (DND.TO) and Galephar Pharmaceutical Research, while Ranbaxy holds the US marketing rights. Post approval, Cipher will receive a $9 million milestone payment from Ranbaxy, ...See all stories on this topic »IDMA-APA Pharmaceutical Analysts' Convention...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news 'National Pharma Pricing Policy may hurt industry in long-run'Hindu Business LinePTI Pharma analysts in India and abroad believe that cost-based pricing in National Pharmaceutical Pricing Policy is not suitable to safeguard the interests of patients as well as the pharma industry. The draft National Pharmaceutical Pricing policy, ...See all stories on this topic »Pharmaceutical firms demand transparent pricing mechanismPakistanToday.com.pkKARACHI - Pharma Bureau, a representative body of multinational pharmaceutical companies in Pakistan, has urged the government to implement a transparent and predictable pricing mechanism for the pharmaceutical industry enabling them to forecast future ...See...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Takeda Pharma to acquire Brazilian-based Multilab for BRL 500 millionpharmabiz.comTakeda Pharmaceutical Company Limited, a research-based global company, and Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda. (Multilab), a leading Brazilian pharmaceutical company, jointly announced that both parties have signed an ...See all stories on this topic »KV Pharmaceutical Company States That Its Policy is Not to Comment on Unusual ...MarketWatch (press release)LOUIS, May 25, 2012 /PRNewswire via COMTEX/ -- KV Pharmaceutical Company (the "Company") today announced that in view of the unusual market activity in the Company's common stock, the NYSE has contacted the Company in accordance with its usual practice ...See all stories on this topic...

Read more »

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee BillMarketWatch (press release)The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate for approving the Food and Drug Administration Safety and Innovation Act (S. 2516), bringing the nation ...See all stories on this topic »Takeda Pharmaceutical: To Acquire Brazil's Multilab Industria For BRL500M In CashWall Street JournalTOKYO (Dow Jones)--Takeda Pharmaceutical Co. (4502.TO) said Friday it will acquire Brazil's Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for BRL500 million ($246 million) in an all-cash deal,...

Read more »